the firm's post-grant practitioners are some of the most experienced in the country.

Technologies

Artificial Intelligence (AI)
Artificial Intelligence (AI)
Digital Health
Digital Health
Energy & Renewables
Energy & Renewables

Fast Facts

About Our

Law Firm

About Our Law Firm

Headquartered within steps of the USPTO with an affiliate office in Tokyo, Oblon is one of the largest law firms in the United States focused exclusively on intellectual property law.

Get to know our

History

Get to know our History

1968
Norman Oblon with Stanley Fisher and Marvin Spivak launched what was to become Oblon, McClelland, Maier & Neustadt, LLP, one of the nation's leading full-service intellectual property law firms.

Our Local and

Global Reach

Our Local and Global Reach

Outside the US, we service companies based in Japan, France, Germany, Italy, Saudi Arabia, and farther corners of the world. Our culturally aware attorneys speak many languages, including Japanese, French, German, Mandarin, Korean, Russian, Arabic, Farsi, Chinese.

A few of our

ACCOLADES

A few of our ACCOLADES

Oblon's professionals provide industry-leading IP legal services to many of the world's most admired innovators and brands.

OPPORTUNITIES FOR YOUR

Career

OPPORTUNITIES FOR YOUR Career

From the minute you walk through our doors, you'll become a valuable part of a team that fosters a culture of innovation, client service and collegiality.

A few ways to

GET In Touch

A few ways to GET In Touch
US Office

Telephone: 703-413-3000
Learn More +


Tokyo Office

Telephone: +81-3-6212-0550
Learn More +

Downloadable

Patent Forms

Downloadable Patent Forms

The United States Patent and Trademark Office (USPTO) issued final rules implementing the inventor's oath or declaration provisions of the America Invents Act (AIA) on August 14, 2012.

Stay informed with

Our Blogs

Jiayi Li, Ph.D.

E: jli@oblon.com
T: (703) 413-2374
F: (703) 413-2220
Download Summary PDF
Download Detailed PDF

Jiayi Li, Ph.D., is a Technical Advisor in the firm’s Chemical Patent Prosecution group where she focuses on drafting patent applications for both domestics and international clients. With a strong background in organic and medicinal chemistry, Dr. Li leverages her extensive graduate/post-graduate research and regulatory experience to offer expertise across a wide range of areas, including organic chemistry, medicinal chemistry, pharmaceutical sciences, and life sciences.

Dr. Li obtained her Ph.D. in Organic Chemistry from Wayne State University in Detroit, MI. Her doctoral research focused on the development of stereoselective glycosylation reactions using small organic molecules as catalysts. This work involved organic synthesis, computational modeling, and intermediate identification, leading to the discovery of new reaction mechanisms. Additionally, Dr. Li investigated synthetic carbohydrate memetics both in silico and in vitro targeting heparanase inhibition. After completing her Ph.D., she joined Massachusetts Institute of Technology as a postdoctoral researcher, where she focused on developing methods in photocatalysis.

Prior to joining the firm, Dr. Li was awarded an ORISE fellowship in the Center of Drug Evaluation at the U.S. Food and Drug Administration. Her work involved development of validated analytical methods to assess the identity, composition, content, and higher order or microstructure of complex drugs employing a range of techniques, including nuclear magnetic resonance (NMR), dynamic light scattering (DLS), and fast protein liquid chromatography (FPLC).


Education

  • Wayne State University (Ph.D.)
    • Organic Chemistry
  • University of Iowa (B.S.)
    • Chemical Engineering

Technical Publications

  • Yu, F.; Li, J.; DeMent, P. M.; Tu, Y.; Schlegel, H. B.; Nguyen, H. M. “Phenanthroline-Catalyzed Stereoretentive Glycosylations.” Angew. Chem. Int. Ed. 2019, 58(21), 6957-6961
  • Zhu, S.; Li, J.; Loka, R. S.; Vlodavsky, I.; Zhang, K.; Nguyen, H. M. “Modulating Heparanase Activity: Tuning Sulfation Pattern and Glycosidic Linkage of Oligosaccharides.” J. Med. Chem. 2020, 63(8), 4227-4255
  • Li, J.; Nguyen, H. M. “A Mechanistic Probe into 1,2-cis Glycoside Formation Catalyzed by Phenanthroline and Further Expansion of Scope.” Adv. Synth. Catal. 2021, 363(16), 4054-4066
  • Xu, H.; Schaugaard, R. N.*; Li, J.*; Schlegel, H. B.; Nguyen, H. M. “Phenanthroline-Catalyzed Stereoselective 1,2-cis Furanosylations.” J. Am. Chem. Soc. 2022, 144(16), 7441-7456
  • Li, J.; Nguyen, H. M. “Phenanthroline Catalysis in Stereoselective 1,2-cis Glycosylations.” Acc. Chem. Res. 2022, 55(24), 3788-3751
  • Abdulsalam, H.; Li, J.; Loka, Ravi S.; Sletten, E. T.; Nguyen, H. M. "Sulfated Glucosamine-Glucuronic Acid Disaccharide Functionalized Polymers Have a High Affinity for the SARS-CoV-2 Spike Protein.” ACS Med. Chem. Lett. 2023, 14, 1411-1418.
  • Wang, D.; Li, J.; Chen, K. Intact NMR Approach Quickly Reveals Synchronized Microstructural Changes in Oil-in-Water Nanoemulsion Formulations. AAPS J. 2024, 26, 78.
  • Li, J.; Chen, F.; Zhang, D.; Wang, Y.; Kozak, D.; Chen, K.; “An Accurate and Fast Quantitative 31P NMR Assay Method for Oligonucleotide Therapeutics.” Anal. Chem. 2024, 96(42), 16514-16519

Languages

  • Chinese - Mandarin
  • Chinese - Cantonese

Services

Technologies